RS

Regina Salvat

Regina Salvat is the current Director at Pionyr Immunotherapeutics. Prior to this, they were with Bolt Biotherapeutics, Inc. from January 2021 to February 2021 as a Board Observer. Regina has also held positions at CinCor Pharma, Inc., Atsena Therapeutics, Aerovate Therapeutics, Inc., Sofinnova Investments, Rubius Therapeutics, and Huron. Regina started their career in 2008 as a Senior Associate Scientist at Pfizer before becoming a Consultant at Avitide, Inc. in 2013.

Regina Salvat completed their PhD at Dartmouth College in Protein & Immuno-Engineering. Regina was a Clare Boothe Luce Fellow and Dartmouth Innovation Fellow during their time at Dartmouth. Prior to their PhD, Salvat completed their M.Eng at Cornell University in Biomedical Engineering (Drug Delivery) as Valedictorian. Regina also completed their B.S. at Cornell University in Biological and Environmental Engineering. Regina Salvat also holds a MIT Fermentation Technology Certificate.

Links


Org chart

This person is not in the org chart